Caregiver does not come into contact with the patient’s skin nor require probe covers, reducing the risk of cross-contamination and eliminating unnecessary costs
DELRAY BEACH, Fla., May 21, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the Caregiver® non-contact thermometer at the American Association of Critical-Care Nurses (AACN) National Teaching Institute and Critical Care Exposition from May 22-24 at the Boston Convention and Exhibition Center in Boston, MA.
Caregiver, FDA cleared for clinical use, is a professional grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds.
Since Caregiver does not touch the patient’s skin, it reduces the risk of cross-contamination, which is an increasing concern due to the rise of difficult-to-treat superbugs like Candida Auris that are spread from skin contact. It also saves healthcare facilities the cost of probe covers (up to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone.
PositiveID’s Thermomedics team is exhibiting at the AACN conference to increase exposure and awareness for Caregiver and generate qualified leads for its national network of distributors.
The sold-out AACN Critical Care Exposition is the largest, most comprehensive trade show for acute and critical care nurses, advanced practice nurses, clinical nurse specialists, nurse practitioners and nurse managers as well as progressive care, transport and emergency department nurses who treat critically ill patients. AACN's audience is estimated at approximately 7,000 influential nurses.
About PositiveID Corporation
PositiveID Corporation is a holding company with a focus on life sciences tools and diagnostics. PositiveID’s ExcitePCR subsidiary develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID’s Thermomedics subsidiary markets the FDA-cleared Caregiver® non-contact infrared thermometer. PositiveID also owns a minority interest in E-N-G Mobile Systems, a leader in the specialty vehicle market. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
Statements about PositiveID's future expectations, including the likelihood that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to raise capital; the Company’s ability to target the professional healthcare market; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 2, 2018, and 10-Qs filed on May 18, 2018, November 13, 2017, and August 14, 2017, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
PositiveID CorporationAllison Tomek
Source: PositiveID Corporation